Search

everythinglearnresearchcommunity

for

Search:↓

The document concludes that assessing hair follicle damage due to cyclophosphamide in mice involves analyzing structural changes and suggests a scoring system for standardized evaluation.

Diagnose and manage hair issues in women by checking medical conditions and using personalized treatments.

Combination therapy promotes better hair growth and density.

Combining topical dutasteride with microneedling is more effective for hair growth than microneedling alone.

New treatments for Alopecia Areata show promise but need to be more effective and affordable.

New alopecia treatments aim for better results and fewer side effects.

New treatments for hair loss show promise, but more research is needed to confirm their safety and effectiveness.

Platelet-rich plasma (PRP) is a safe and potentially effective way to treat hair loss, especially when combined with minoxidil.

Minoxidil effectively and safely treats patchy hair loss, but more research needed.

Hydroxychloroquine may help treat alopecia areata in children.

Azathioprine is the most continued treatment for chronic alopecia areata over a year, often with added low-dose prednisolone.

Oral tofacitinib has a moderate success rate and is generally safe for treating hair loss in some patients.

The guidelines offer updated treatment recommendations for alopecia areata in Korea using topical and device-based methods.

Injecting platelet-rich plasma or applying it with a laser or microneedling can treat hair loss effectively. The laser and microneedling methods cause less pain.

Upadacitinib may cause hair loss.

Caffeine shows promise for treating some types of hair loss, but more research is needed.

Corticosteroids may not effectively control oxidative stress in alopecia areata, possibly leading to relapses.

Alopecia areata affects quality of life more in adolescents than adults.

A standard protocol for alopecia areata clinical trials was created to improve consistency and encourage more research.

The analysis aims to identify the most effective and safest treatments for alopecia areata.

JAK inhibitors show promise as a future treatment for hair loss.

Tofacitinib helps hair regrowth in alopecia areata but relapse is common after stopping treatment.

JAK inhibitors effectively regrow hair in alopecia areata but hair loss often returns after stopping treatment.

Baseline severity and relapse history affect alopecia areata treatment and recurrence.

People with alopecia areata have a higher risk of heart disease.

Tofacitinib effectively promotes hair regrowth in alopecia areata with minimal side effects.

Ritlecitinib is safe and well-tolerated for treating alopecia areata in patients aged 12 and older.

Low-dose oral minoxidil is generally safe for treating hair loss, with mostly mild side effects.

DPCP immunotherapy is effective for alopecia areata, and understanding influencing factors can improve treatment and satisfaction.

Comprehensive screening for infections is crucial before starting JAK inhibitors in alopecia areata patients.